berberine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
Excerpt | Relevance | Reference |
---|---|---|
"Treating BCR-ABL-positive chronic myeloid leukemia remains impeded by the development of clinical resistance to imatinib." | 1.56 | "All Our Wisdom is Stored in the Trees" - Degrading BCR-ABL with ( Elf, SE, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Huang, G | 1 |
Yin, Z | 1 |
Wang, X | 1 |
Wen, Z | 1 |
Su, R | 1 |
Li, C | 1 |
Liu, Y | 1 |
Yang, J | 1 |
Hu, H | 1 |
Nie, H | 1 |
Zeng, X | 1 |
Fei, J | 1 |
Elf, SE | 1 |
2 other studies available for berberine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Article | Year |
---|---|
System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
Topics: Animals; Berberine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; | 2023 |
"All Our Wisdom is Stored in the Trees" - Degrading BCR-ABL with
Topics: Antineoplastic Agents; Benzamides; Berberine; Berberis; Drug Resistance, Neoplasm; Fusion Proteins, | 2020 |